Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Belen Moreno-Castaño A"'
Autor:
Alvaro Urbano-Ispizua, Sara Fernández, Pedro Castro, Francesc Fernández-Avilés, Enric Carreras, Adrián Téllez, Valentín Ortiz-Maldonado, Carlos Fernández de Larrea, Julio Delgado, Olaf Penack, Ana Belen Moreno-Castaño, Helena Ventosa, Marta Palomo, Julia Martinez-Sanchez, Alex Ramos, J M Nicolás, Gines Escolar, Maribel Diaz-Ricart
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 4 (2023)
Background Chimeric antigen receptor (CAR)-T cell-based immunotherapy constitutes a revolutionary advance for treatment of relapsed/refractory hematological malignancies. Nevertheless, cytokine release and immune effector cell-associated neurotoxicit
Externí odkaz:
https://doaj.org/article/596812ed16e74fdfbda10735d5315b0e
Autor:
Gerard Espinosa, Carles Zamora-Martínez, Albert Pérez-Isidro, Daniela Neto, Luz Yadira Bravo-Gallego, Sergio Prieto-González, Odette Viñas, Ana Belen Moreno-Castaño, Estíbaliz Ruiz-Ortiz, Ricard Cervera, The COVAPS-CLINIC Study Group Investigators, Alex Almuedo, Giuseppe Barilaro, Daniel Camprubí, Júlia Calvo, Aina Capdevila-Reniu, Irene Carbonell, Georgina Espígol-Frigolé, Cristina Gabara, Priscila Giavedoni, Ignacio Grafia, Andrea Ladino, Gema Maria Lledó-Ibáñez, Ana Matas-García, Pere Millat, Pedro Juan Moreno, Magdalena Muelas, José Muñoz, José Naval, Joan Padrosa, Martina Pellicé, María Jesús Pinazo, Roberto Ríos-Garcés, Natalia Rodríguez, Olga Rodríguez-Núñez, Estibaliz Ruiz-Ortiz, Ruth Sotil, Adrià Tomé, Helena Ventosa
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
ObjectivePatients with COVID-19 presented with an elevated prevalence of antiphospholipid antibodies (aPL) but the relationship with thrombosis is controversial. We analysed the persistence of aPL and their association with the clinical outcomes duri
Externí odkaz:
https://doaj.org/article/53b05196ad4f4b00976405b5241bd202
Autor:
Manuel Serrano, Gerard Espinosa, Antonio Lalueza, Luz Yadira Bravo‐Gallego, Raquel Diaz‐Simón, Sara Garcinuño, Javier Gil‐Etayo, Jorge Moises, Laura Naranjo, Sergio Prieto‐González, Estibaliz Ruiz‐Ortiz, Beatriz Sánchez, Ana Belen Moreno‐Castaño, Carmen Díaz‐Pedroche, Odette Viñas‐Gomis, Ricard Cervera, Antonio Serrano, the APS‐COVID 19 Study Group/European Forum on Antiphospholipid Antibodies
Publikováno v:
ACR Open Rheumatology, Vol 3, Iss 4, Pp 267-276 (2021)
Objective Patients with coronavirus disease 2019 (COVID‐19) present coagulation abnormalities and thromboembolic events that resemble antiphospholipid syndrome (APS). This work has aimed to study the prevalence of APS‐related antigens, antibodies
Externí odkaz:
https://doaj.org/article/fcb0095a4c2c4cb3b7a0b7e4c639ea64
Autor:
Julia Martinez-Sanchez, Hannah Hamelmann, Marta Palomo, Enrique Mir, Ana Belen Moreno-Castaño, Sergi Torramade, Montserrat Rovira, Ginés Escolar, Steffen Cordes, Martina Kalupa, Sarah Mertlitz, Katarina Riesner, Enric Carreras, Olaf Penack, Maribel Diaz-Ricart
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Angiogenesis and endothelial activation and dysfunction have been associated with acute graft-vs.-host disease (aGVHD), pointing to the endothelium as a potential target for pharmacological intervention. Defibrotide (DF) is a drug with an endothelium
Externí odkaz:
https://doaj.org/article/629b5b5560574de1b56d5a24b3265d3f
Autor:
Maribel Diaz-Ricart, Sergi Torramade-Moix, Georgina Pascual, Marta Palomo, Ana Belen Moreno-Castaño, Julia Martinez-Sanchez, Manel Vera, Aleix Cases, Gines Escolar
Publikováno v:
Toxins, Vol 12, Iss 6, p 361 (2020)
Chronic kidney disease (CKD) patients have an accelerated atherosclerosis, increased risk of thrombotic-ischemic complications, and excessive mortality rates when compared with the general population. There is also evidence of an endothelial damage i
Externí odkaz:
https://doaj.org/article/7a16de4c9c6c4e9fa37b3670ac88df50
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ferran Segui, Helena Ventosa, Paul G. Richardson, Enric Carreras, Carmelo Carlo-Stella, Gines Escolar, Sara Fernández, Pedro Castro, Ana Belen Moreno-Castaño, Sergi Torramade-Moix, Edward Richardson, Maribel Diaz-Ricart, Marta Palomo, José M. Moraleda, Julia Martinez-Sanchez, Josep M. Nicolás, Adrián Téllez, David García-Bernal
Publikováno v:
Shock (Augusta, Ga.)
Shock
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Shock
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Background: Endotheliopathy is a key element in COVID-19 pathophysiology, contributing to both morbidity and mortality. Biomarkers distinguishing different COVID-19 phenotypes from sepsis syndrome remain poorly understood. Objective: To characterize
Autor:
Georgina Pascual, Enric Carreras, Paul G. Richardson, Ana Belen Moreno-Castaño, Marta Palomo, Julia Martinez-Sanchez, Edward Richardson, Josep M. Nicolás, Juan J. Badimon, Sara Fernández, Adrián Téllez, Maribel Diaz-Ricart, Gines Escolar, Sergi Torramade-Moix, Pedro Castro
Publikováno v:
Cardiovascular Drugs and Therapy
Patients with COVID-19 present a wide spectrum of disease severity, from asymptomatic cases in the majority to serious disease leading to critical care and even death. Clinically, four different scenarios occur within the typical disease timeline: fi
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ana Belen Moreno-Castaño, Sara Fernández, Helena Ventosa, Marta Palomo, Julia Martinez-Sanchez, Alex Ramos, Valentín Ortiz-Maldonado, Julio Delgado, Carlos Fernández de Larrea, Alvaro Urbano-Ispizua, Olaf Penack, J M Nicolás, Adrian Téllez, Gines Escolar, Enric Carreras, Francesc Fernández-Avilés, Pedro Castro, Maribel Diaz-Ricart
Publikováno v:
Journal for ImmunoTherapy of Cancer. 11:e006365
BackgroundChimeric antigen receptor (CAR)-T cell-based immunotherapy constitutes a revolutionary advance for treatment of relapsed/refractory hematological malignancies. Nevertheless, cytokine release and immune effector cell-associated neurotoxicity